About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Innovation Engine New Era Microbiome Therapeutics Discuva Platform Scientific Literature & Publications Investors & Media Investor Center Media Center Press Releases Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Summit Presentations Careers
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD)
Efficacy Of SMT19969 And SMT21829 In A Hamster Model Of Clostridium Difficile Associated Disease (CDAD) September 10, 2011 By CKD Digital